Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
621.00    -2.00 (-0.32%)
Bid:
619.00
Ask:
621.00
Spread: 2.00 (0.323%)
Market Cap: £502.04m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Director/PDMR Shareholding

28 Sep 2009 15:36

RNS Number : 7845Z
Bloomsbury Publishing PLC
28 September 2009
 



For immediate release 28th September 2009

Bloomsbury Publishing Plc

("Bloomsbury" or "the Company")

Notification of Interests of Directors and Persons Discharging Managerial Responsibility ("PDMR") and connected persons

Bloomsbury announces the following changes to the interests of Directors and PDMRs in the Company's ordinary shares of 1.25p each ("Shares").

On 25 September 2009 the Company made the following awards of Shares ("Awards") under the Bloomsbury Performance Share Plan 2005 ("PSP"):

Executive Directors

Name

Role

PSP Award (number)

Total PSP Awards 

(including current award) 

Beneficial interest in shares (number excluding Awards)

Nigel Newton

Chief Executive

235,820

610,810

2,258,488

Colin Adams

Group Finance Director

117,189

282,778

50,000

Richard Charkin

Executive Director

169,189

465,037

12,000

The total number of Shares awarded to Executive Directors under the PSP is equal to 1.84 % of the issued share capital of the Company.

The Executive Directors have a total beneficial interest (excluding PSP Awards) in 3.15% of the issued share capital of the Company.

PDMRs

Name

PSP Award (number)

Total Awards

(including current award)

Kathy Rooney

45,278

144,181

Jill Coleman 

52,446

204,393

Jonathan Glasspool

39,220

74,907

Awards granted under the PSP will vest on 25th September 2012, but only to the extent that certain performance criteria based on earnings per share growth and total shareholder return are satisfied by the Company over a three year performance period. No consideration is payable for the grant of the Awards and the receipt of Shares is conditional upon meeting the performance criteria. It is intended that the Company's employee benefit trust will acquire shares (either by way of subscription for new shares, market purchase or from treasury) necessary to fulfil any obligation arising from the vesting of the Awards.

The notification of these Awards is intended to satisfy the Company's obligations under Disclosure Rule 3.1.4.

Ian Portal

Group Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBSGDCSXDGGCI
Date   Source Headline
22nd May 20257:00 amRNSAnnual Financial Report
15th May 20257:00 amRNSNotice of Preliminary Results
15th Apr 20257:00 amRNSAppointment of Joint Corporate Broker
20th Mar 20257:00 amRNSTrading Update and Board Appointment
3rd Mar 20257:00 amRNSNotice of Trading Update
24th Feb 20254:27 pmRNSHolding(s) in Company
14th Feb 202510:05 amRNSBLOCK LISTING SIX MONTHLY RETURN
24th Jan 20257:00 amRNSBloomsbury reaches new agreement with Amazon
16th Dec 202410:05 amRNSHolding(s) in Company
16th Dec 20249:55 amRNSHolding(s) in Company - Replacement
11th Dec 202410:24 amRNSDirector/PDMR Shareholding
9th Dec 20249:18 amRNSDirector/PDMR Shareholding
26th Nov 202411:44 amRNSHolding(s) in Company
26th Nov 202410:35 amRNSDirector/PDMR Shareholding
24th Oct 20247:00 amRNSUnaudited Interim Results
30th Sep 20247:00 amRNSNotice of Interim Results
2nd Sep 202411:31 amRNSDirector/PDMR Shareholding
29th Aug 20247:00 amRNSDirector/PDMR Shareholding
28th Aug 202410:57 amRNSDirector/PDMR Shareholding
16th Aug 20244:18 pmRNSAMENDMENT: BLOCK LISTING SIX MONTHLY RETURN
16th Aug 20249:42 amRNSBLOCK LISTING SIX MONTHLY RETURN
7th Aug 20245:36 pmRNSAwards under the 2023 Executive Share Plan
16th Jul 20243:41 pmRNSResults of the 2024 Annual General Meeting
16th Jul 20247:00 amRNSAGM Trading Update
14th Jun 20245:01 pmRNSAnnual Financial Report
14th Jun 20241:48 pmRNSBoard Appointment
29th May 20247:00 amRNSAcquisition
23rd May 20247:00 amRNSChairman Succession Announcement
23rd May 20247:00 amRNSAudited Preliminary Results
20th May 20247:00 amRNSInvestor Presentation
16th Feb 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
14th Feb 20247:00 amRNSTrading Update
1st Feb 20243:11 pmRNSBloomsbury launches latest Sarah J. Maas novel
15th Jan 20247:00 amRNSBloomsbury Appoints Head of Investor Relations
12th Jan 202411:45 amRNSHolding(s) in Company
9th Jan 20244:10 pmRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSTrading Update
15th Nov 20237:00 amRNSBlocklisting Application
31st Oct 20237:00 amRNSInvestor Presentation
26th Oct 20237:00 amRNSUnaudited Interim Results
9th Oct 20231:00 pmRNSBloomsbury playwright Jon Fosse wins Nobel Prize
22nd Sep 20231:26 pmRNSDirector/PDMR Shareholdings - Correction
14th Sep 20237:00 amRNSBloomsbury launches new book by Katherine Rundell
5th Sep 20237:00 amRNSDirector/PDMR Shareholding
1st Sep 20232:05 pmRNSDirector/PDMR Shareholding
30th Aug 20231:56 pmRNSDirector/PDMR Shareholding
29th Aug 20232:11 pmRNSDirector/PDMR Shareholding
23rd Aug 20237:00 amRNSHolding(s) in Company
22nd Aug 20238:00 amRNSBloomsbury enjoys bestseller success
17th Aug 20234:40 pmRNSBLOCK LISTING SIX MONTHLY RETURN

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.